Role of microRNA-520h in 20(R)-ginsenoside-Rg3-mediated angiosuppression

Journal of Ginseng Research

Volumn 40, Issue 2, 2016, Pages 151-159

  Keung, Man Hong ^a   Chan, Lai Sheung ^a   Kwok, Hoi Hin ^a   Wong, Ricky Ngok Shun ^a   Yue, Patrick Ying Kit ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

anti angiogenesis; ginsenoside Rg3; microRNA; miR 520h

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4; GINSENOSIDE RG 3; MICRORNA; MICRORNA 197; MICRORNA 219; MICRORNA 23A; MICRORNA 342; MICRORNA 377; MICRORNA 487B; MICRORNA 489; MICRORNA 520H; MICRORNA 524; UNCLASSIFIED DRUG; VASCULOTROPIN;

3' UNTRANSLATED REGION; ANGIOGENESIS ASSAY; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO (ANATOMY); GAIN OF FUNCTION MUTATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GINSENG; HUMAN; HUMAN CELL; HUVEC CELL LINE; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING; ZEBRA FISH;

EID: 85012047252     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2015.07.002     Document Type: Article

References (36)

1. Chen, J., Peng, H., Ou-Yang, X., He, X., Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res 18 (2008), 322–329.
2. Mochizuki, M., Yoo, Y.C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K., Azuma, I., Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 18 (1995), 1197–1202.
3. Yue, P.Y., Wong, D.Y., Wu, P.K., Leung, P.Y., Mak, N.K., Yeung, H.W., Liu, L., Cai, Z., Jiang, Z.H., Fan, T.P., et al. The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 72 (2006), 437–445.
4. Liu, T.G., Huang, Y., Cui, D.D., Huang, X.B., Mao, S.H., Ji, L.L., Song, H.B., Yi, C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 9 (2009), 1471–2407.
5. Zhang, Q., Kang, X., Yang, B., Wang, J., Yang, F., Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother Radiopharm 23 (2008), 647–653.
6. Xu, T.M., Xin, Y., Cui, M.H., Jiang, X., Gu, L.P., Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J (Engl) 120 (2007), 584–588.
7. Huang, X., Hou, M., Yi, C., Song, H., Anti-angiogenic effects of low-dose gemcitabine combined with ginsenoside Rg3 on mouse Lewis lung carcinoma. Zhongguo Fei Ai Za Zhi 9 (2006), 132–136 [Chinese].
8. Kang, X.M., Zhang, Q.Y., Tong, D.D., Zhao, W., Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3. Zhongguo Zhong Xi Yi Jie He Za Zhi 25 (2005), 730–733 [Chinese].
9. Chen, M.W., Ma, A.Q., Ni, L., Huang, C., Zhang, D.Z., Niu, X.Y., Effect of ginsenoside on the cellular proliferation, apoptosis and cell cycles in LC A549 and HUVEC 304 cell lines. Zhong Nan Da Xue Xue Bao Yi Xue Ban 30 (2005), 149–152 [Chinese].
10. Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
11. Kim, V.N., Nam, J.W., Genomics of microRNA. Trends Genet 22 (2006), 165–173.
12. Ambros, V., The functions of animal microRNAs. Nature 431 (2004), 350–355.
13. Erson, A.E., Petty, E.M., MicroRNAs in development and disease. Clin Genet 74 (2008), 296–306.
14. Chan, L.S., Yue, P.Y., Mak, N.K., Wong, R.N., Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 38 (2009), 370–377.
15. Chan, L.S., Yue, P.Y., Wong, Y.Y., Wong, R.N., MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem Pharmacol 86 (2013), 392–400.
16. Chan, Y.K., Kwok, H.H., Chan, L.S., Leung, K.S., Shi, J., Mak, N.K., Wong, R.N., Yue, P.Y., An indirubin derivative, E804, exhibits potent angiosuppressive activity. Biochem Pharmacol 83 (2012), 598–607.
17. Nagpal, M., Nagpal, K., Nagpal, P.N., A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin). Indian J Ophthalmol 55 (2007), 437–439.
18. Scapoli, L., Palmieri, A., Lo Muzio, L., Pezzetti, F., Rubini, C., Girardi, A., Farinella, F., Mazzotta, M., Carinci, F., MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23 (2010), 1229–1234.
19. Hromadnikova, I., Kotlabova, K., Jirasek, J.E., Doucha, J., Detection of placenta-specific microRNAs in maternal circulation. Ceska Gynekol 75 (2010), 252–256 [Czech].
20. Su, J.L., Chen, P.B., Chen, Y.H., Chen, S.C., Chang, Y.W., Jan, Y.H., Cheng, X., Hsiao, M., Hung, M.C., Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res 70 (2010), 5096–5108.
21. Yu, Y.H., Chen, H.A., Chen, P.S., Cheng, Y.J., Hsu, W.H., Chang, Y.W., Chen, Y.H., Jan, Y., Hsiao, M., Chang, T.Y., et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 32 (2013), 431–443.
22. Wang, F., Xue, X., Wei, J., An, Y., Yao, J., Cai, H., Wu, J., Dai, C., Qian, Z., Xu, Z., et al. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 103 (2010), 567–574.
23. Cheng, N., Brantley, D.M., Chen, J., The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13 (2002), 75–85.
24. Zhang, J., Hughes, S., Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 208 (2006), 453–461.
25. Salvucci, O., Tosato, G., Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114 (2012), 21–57.
26. Adams, R.H., Wilkinson, G.A., Weiss, C., Diella, F., Gale, N.W., Deutsch, U., Risau, W., Klein, R., Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13 (1999), 295–306.
27. Steinle, J.J., Meininger, C.J., Forough, R., Wu, G., Wu, M.H., Granger, H.J., Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 277 (2002), 43830–43835.
28. Heroult, M., Schaffner, F., Augustin, H.G., Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312 (2006), 642–650.
29. Kuijper, S., Turner, C.J., Adams, R.H., Regulation of angiogenesis by Eph–ephrin interactions. Trends Cardiovasc Med 17 (2007), 145–151.
30. Sawamiphak, S., Seidel, S., Essmann, C.L., Wilkinson, G.A., Pitulescu, M.E., Acker, T., Acker-Palmer, A., Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465 (2010), 487–491.
31. Wang, Y., Nakayama, M., Pitulescu, M.E., Schmidt, T.S., Bochenek, M.L., Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lüthi, U., et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465 (2010), 483–486.
32. Horowitz, A., Seerapu, H.R., Regulation of VEGF signaling by membrane traffic. Cell Signal 24 (2012), 1810–1820.
33. Yue, P.Y., Wong, D.Y., Ha, W.Y., Fung, M.C., Mak, N.K., Yeung, H.W., Leung, H.W., Chan, K., Liu, L., Fan, T.P., et al. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro. Angiogenesis 8 (2005), 205–216.
34. Chan, L.S., Yue, P., Kok, T.W., Keung, M.H., Mak, N.K., Wong, R., Ginsenoside-Rb1 promotes adipogenesis through regulation of PPARγ and microRNA-27b. Horm Metab Res 44 (2012), 819–824.
35. Kwok, H.H., Yue, P.Y.K., Mak, N.K., Wong, R.N.S., Ginsenoside Rb1 induces type I collagen expression through peroxisome proliferator-activated receptor-delta. Biochem Pharmacol 84 (2012), 532–539.
36. 3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma. Biochem Pharmacol 83 (2012), 893–902.